Cargando…

Clinical effectiveness of liraglutide vs basal insulin in a real‐world setting: Evidence of improved glycaemic and weight control in obese people with type 2 diabetes

AIMS: To compare real‐world antidiabetic treatment outcomes over 12 months in obese people with type 2 diabetes mellitus (T2DM) who previously received oral antidiabetic therapy and then initiated a first injectable therapy with liraglutide or basal insulin. PATIENTS AND METHODS: This was a retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Overbeek, Jetty A., Heintjes, Edith M., Huisman, Eline L., Tikkanen, Christian K., van Diermen, Arnout W., Penning‐van Beest, Fernie J.A., Herings, Ron M.C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099315/ https://www.ncbi.nlm.nih.gov/pubmed/29726082 http://dx.doi.org/10.1111/dom.13335

Ejemplares similares

Dupuytren's contracture: a retrospective database analysis to determine hospitalizations in the Netherlands
por: Overbeek, Jetty A, et al.
Publicado: (2011)

Completeness and Representativeness of the PHARMO General Practitioner (GP) Data: A Comparison with National Statistics
por: Overbeek, Jetty A, et al.
Publicado: (2023)

Relation Between Different Measures of Glycemic Exposure and Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes Mellitus: An Observational Cohort Study
por: van Wijngaarden, Rients P. T., et al.
Publicado: (2017)

Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany
por: Smits, Elisabeth, et al.
Publicado: (2022)

Existing Data Sources for Clinical Epidemiology: The PHARMO Database Network
por: Kuiper, Josephina G, et al.
Publicado: (2020)

Occurrence of Comorbidities before and after Soft Tissue Sarcoma Diagnosis
por: van Herk-Sukel, Myrthe P. P., et al.
Publicado: (2012)

Liraglutide and Glycaemic Outcomes in the LEADER Trial
por: Zinman, Bernard, et al.
Publicado: (2018)

Increased Risk of Stroke Due to Non-adherence and Non-persistence with Direct Oral Anticoagulants (DOACs): Real-World Analyses Using a Nested Case–Control Study from The Netherlands, Italy and Germany
por: Holthuis, Emily, et al.
Publicado: (2022)

Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride
por: Kuiper, Josephina G., et al.
Publicado: (2016)

Characteristics and first treatment dose of Dutch patients (12-60 years old) receiving prescriptions for asthma and initiating inhaled corticosteroids (ICS) therapy as either extra-fine (EF) ciclesonide or standard-particle (SP)-ICS
por: Van Eickles, Daniela, et al.
Publicado: (2015)

Insulin degludec/liraglutide (IDegLira) maintains glycaemic control and improves clinical outcomes, regardless of pre‐trial insulin dose, in people with type 2 diabetes that is uncontrolled on basal insulin
por: Meneghini, L., et al.
Publicado: (2019)

Basal insulin initiation in primary vs. specialist care: similar glycaemic control in two different patient populations
por: Orozco‐Beltran, D., et al.
Publicado: (2016)

Incidence of Lyme Borreliosis in the Dutch General Practice Population: A Large-Scale Population-Based Cohort Study Across the Netherlands Between 2015 and 2019
por: Houben, Eline, et al.
Publicado: (2023)

Sex- and site-specific differences in colorectal cancer risk among people with type 2 diabetes
por: Overbeek, Jetty A., et al.
Publicado: (2018)

Identification of frailty in primary care: accuracy of electronically derived measures
por: Swart, Karin MA, et al.
Publicado: (2023)

Loss of treatment benefit due to low compliance with bisphosphonate therapy
por: Penning-van Beest, F. J. A., et al.
Publicado: (2007)

Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries
por: Heintjes, Edith M, et al.
Publicado: (2020)

Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections
por: Sofizadeh, Sheyda, et al.
Publicado: (2019)

An evaluation of exact matching and propensity score methods as applied in a comparative effectiveness study of inhaled corticosteroids in asthma
por: Burden, Anne, et al.
Publicado: (2017)

Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes
por: Ericsson, Åsa, et al.
Publicado: (2018)

Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands
por: Swart, Karin M. A., et al.
Publicado: (2023)

The DIAbetes MANagement and Treatment (DIAMANT) Cohort
por: Overbeek, Jetty A, et al.
Publicado: (2022)

Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA
por: Mauricio, Dídac, et al.
Publicado: (2017)

Effectiveness of COVID-19 Vaccines in Adults with Diabetes Mellitus: A Systematic Review
por: van den Berg, Jesse M., et al.
Publicado: (2022)

Glycaemic impact of treatment intensification in patients with type 2 diabetes uncontrolled with oral antidiabetes drugs or basal insulin
por: Buysman, Erin K., et al.
Publicado: (2018)

Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline data
por: Peters, Anne, et al.
Publicado: (2020)

Patient‐led rapid titration of basal insulin in gestational diabetes is associated with improved glycaemic control and lower birthweight
por: McGovern, Andrew P., et al.
Publicado: (2022)

The role of GLP-1 mimetics and basal insulin analogues in type 2 diabetes mellitus: guidance from studies of liraglutide
por: Barnett, A H
Publicado: (2012)

Cardiovascular outcomes and healthcare costs of liraglutide versus basal insulin for type 2 diabetes patients at high cardiovascular risk
por: Huang, Wan-Chun, et al.
Publicado: (2021)

Effects of low glycaemic index/low glycaemic load vs. high glycaemic index/ high glycaemic load diets on overweight/obesity and associated risk factors in children and adolescents: a systematic review and meta-analysis
por: Schwingshackl, Lukas, et al.
Publicado: (2015)

When basal insulin is not enough: A dose–response relationship between insulin glargine 100 units/mL and glycaemic control
por: Umpierrez, Guillermo E., et al.
Publicado: (2019)

Managing insulin resistance: role of liraglutide
por: Kalra, Sanjay, et al.
Publicado: (2010)

The Glycaemic Index-Food-Frequency Questionnaire: Development and Validation of a Food Frequency Questionnaire Designed to Estimate the Dietary Intake of Glycaemic Index and Glycaemic Load: An Effort by the PREVIEW Consortium
por: Brouwer-Brolsma, Elske M., et al.
Publicado: (2018)

Preserved pharmacokinetics and pharmacodynamics of insulin degludec and liraglutide when administered as insulin degludec/liraglutide in a Chinese population
por: Liu, Hongzhong, et al.
Publicado: (2021)

Weekly Semaglutide vs. Liraglutide Efficacy Profile: A Network Meta-Analysis
por: Alsugair, Hassan A., et al.
Publicado: (2021)

Fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin
por: Vilsbøll, Tina, et al.
Publicado: (2019)

Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands
por: van der Molen, Thys, et al.
Publicado: (2016)

Erratum to: Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands
por: van der Molen, Thys, et al.
Publicado: (2016)

Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10)
por: Brown‐Frandsen, Kirstine, et al.
Publicado: (2019)

Comparison between liraglutide alone and liraglutide in combination with insulin on osteoporotic rats and their effect on bone mineral density
por: Chen, Kai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_53vjccmsmgnrdphek2olh999rf